Solcoseryl ointment 2.07mg /g, 20g — Made in Switzerland — Free Delivery

Pharmacological properties

Pharmacodynamics. Solcoseryl is a deproteinized hemoderivat from the blood of calves, obtained by dialysis and ultrafiltration, with a wide range of natural low molecular weight substances with a molecular weight of 5000 da, only some of which are chemically and pharmacologically described. In in vitro tests, as well as during preclinical and clinical studies, it was revealed that solcoseryl:

• supports aerobic metabolism and oxidative phosphorylation, and also promotes the replenishment of cells with high-energy phosphates that are not receiving sufficient nutrition;
• increases in vitro oxygen utilization and glucose transport to tissues and cells that suffer from hypoxia and are metabolically depleted;
• improves the processes of repair and regeneration of damaged tissues with insufficient nutrition;
• prevents or reduces secondary degradation and pathological changes in reversibly damaged cell systems;
• accelerates collagen synthesis in in vitro models;
• stimulates cell proliferation and migration in vitro.

Thus, Solcoseryl has a protective effect against tissues in a state of hypoxia and nutritional deficiency, promotes their regeneration, and accelerates wound healing.

Pharmacokinetics. The absorption, distribution and elimination of the active component of the preparation Solcoseryl - deproteinized hemoderivat - cannot be studied by conventional pharmacokinetic methods, such as a radioactive label and others, since the protein-free hemoderivat contains a mixture of various molecules with different physicochemical properties.

In the case of topical forms, their action is limited to the site of application, which has been proven by comparing the results of multiple treatments in the same person.

Indications

Minor injuries, venous ulcers, burns of the i – ii degree (for example, from boiling water), frostbite.

Application

Solcoseryl jelly / ointment is applied in a thin layer to the cleansed wound 2 times a day. it is recommended to apply jelly on wet wounds, and ointment on dry ones.

Contraindications

Hypersensitivity to the components of the preparation, especially the known allergy to preservatives: methyl parahydroxybenzoate (e218), propyl parahydroxybenzoate (e216), propylene glycol and trace amounts of free benzoic acid (e210).

Side effects

When using the jelly / ointment, a burning sensation may appear, which does not require discontinuation of the preparation. in rare cases, allergic reactions are possible, and treatment should be discontinued.

Special instructions

When treating according to the instructions, there is no need for special safety methods.

During pregnancy and breastfeeding. When using the preparation in animal studies, no risk to the fetus has been identified. There are no contraindications for using the preparation during lactation. If you have any doubts about the use of the preparation, you should consult a doctor.

The ability to influence the reaction rate when driving and working with other mechanisms. Has not been investigated.

Interactions

Not investigated.

Overdose

No cases of overdose have been reported.

Storage conditions

At a temperature not higher than 30 ° C. after the first opening, store for 28 days at a temperature not exceeding 25 ° C.